Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cell Therapy Repairs Heart Defect in Mouse Model

By LabMedica International staff writers
Posted on 23 Sep 2008
Cardiovascular disease researchers have used stem cells to repair damaged heart muscle in a mouse model of dilated cardiomyopathy, a potentially fatal, congenital heart defect.

Investigators at the Mayo Clinic (Rochester, MN, USA) developed a mouse line where the gene for critical heart-protective proteins called ATP-sensitive (KATP) channel subunits was "knocked-out.” The animals mimicked the symptoms of human dilated cardiomyopathy, typified by poor survival due to compromised heart contractions and ventricular dilation.

In an attempt to repair this condition, the investigators transplanted 200,000 embryonic stem cells into the wall of the left ventricle of the knockout mice. More...
They reported in the July 31, 2008, online edition of the journal Stem Cells that after one month the treatment improved heart performance, synchronized electrical impulses, and stopped heart deterioration. The presence of the lacZ reporter transgene in the rejuvenated heart tissue showed that the stem cells had grafted into the heart to form new cardiac tissue. Stem cell transplantation restarted cell cycle activity in the heart tissue and reduced fibrosis by 50%. Improved systemic function induced by the stem cell therapy translated into increased stamina, absence of swelling due to the accumulation of serous fluids, and benefit to overall survivorship.

"We have shown in this transgenic animal model that embryonic stem cells may offer an option in repairing genetic heart problems,” said first author Dr. Satsuki Yamada, cardiovascular researcher at the Mayo Clinic.

Related Links:
Mayo Clinic



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.